{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:47:40Z","timestamp":1775839660123,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>This article presents a case characterized by recurrent pulmonary infections and a poor therapeutic response. Initially, cystic fibrosis (CF) or Primary ciliary dyskinesia was suspected; however, the patient subsequently sought medical attention for a neck mass. The mass was initially misdiagnosed as lymphoma, but a comprehensive examination and assessment ultimately confirmed the diagnosis of activated phosphoinositide 3-kinase delta syndrome type I(APDS1). Through the patient\u2019s tortuous diagnostic journey, this report aims to enhance clinicians\u2019 understanding of this rare primary immunodeficiency disorder. Clinical picture: The patient is a female adopted child who has experienced recurrent lung infections since the age of 6 months. On average, she has required hospitalization 2\u20133 times annually, with conventional anti-infection treatments proving less effective. Throughout her illness, she was admitted to another hospital for sinusitis and breast cysts, although the specifics of her treatment remain unclear. Subsequently, she presented to our hospital with symptoms of coughing, yellow sputum, and hemoptysis. During her hospitalization, a new neck mass was identified. Key inspection: Imaging assessment revealed a chest CT indicating pulmonary infection and bronchiectasis with mucus plug formation. Neck CT and MRI suggested a potential diagnosis of lymphoma. Pathogen testing through nucleic acid analysis for respiratory pathogens yielded positive results for mycoplasma and adenovirus influenzae. Laboratory and abdominal ultrasound did not identify any abnormalities in the pancreas. A peripheral blood immunological assessment demonstrated significantly diminished cellular and humoral immune functions. Following the resection of the cervical mass, the initial pathological diagnosis was lymphoma; however, tests for T-cell receptor (TCR) and immunoglobulin (IG) gene rearrangements returned negative results. After a multidisciplinary consultation and subsequent pathological re-examination, the diagnosis was revised to infectious mononucleosis. Genetic testing revealed a heterozygous mutation in the PIK3CD gene. Final diagnosis: Activated phosphatidylinositol 3-kinase \u03b4 syndrome type I (APDS1). Treatment and prognosis: Following diagnosis, the child was administered rapamycin-targeted therapy in conjunction with compound sulfamethoxazole to prevent infections, with regular monitoring of rapamycin blood concentrations. Subsequent follow-up indicated a significant reduction in the frequency of pulmonary infection episodes, a decrease in the size of the enlarged lymph nodes in the neck, and effective control of the condition.<\/jats:p>","DOI":"10.3389\/fmed.2026.1807946","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:51:16Z","timestamp":1775836276000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Recurrent pulmonary infections with neck masses: a diagnostic challenge and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Leilei","family":"Zhao","sequence":"first","affiliation":[{"name":"Jinan Children\u2019s Hospital","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianshe","family":"Zhao","sequence":"additional","affiliation":[{"name":"Jinan Children\u2019s Hospital","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[{"name":"Jinan Children\u2019s Hospital","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage.","volume":"342","author":"Angulo","year":"2013","journal-title":"Science."},{"key":"B2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/ni0403-313","article-title":"The role of PI3K in immune cells.","volume":"4","author":"Koyasu","year":"2003","journal-title":"Nat Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"110632","DOI":"10.1016\/j.clim.2025.110632","article-title":"Natural history of clinical manifestations in activated phosphoinositide 3-kinase \u03b4 syndrome (APDS): time-to-event analyses using the European Society for immunodeficiencies-APDS registry.","volume":"283","author":"Maccari","year":"2026","journal-title":"Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"597.e","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study.","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1208567","DOI":"10.3389\/fimmu.2023.1208567","article-title":"Activated PI3K\u03b4 syndrome - reviewing challenges in diagnosis and treatment.","volume":"14","author":"Vanselow","year":"2023","journal-title":"Front Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12016-019-08738-9","article-title":"Clinical, immunological, and genetic features in patients with activated PI3K\u03b4 syndrome (APDS): a systematic review.","volume":"59","author":"Jamee","year":"2020","journal-title":"Clin Rev Allergy Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e2504","DOI":"10.1002\/pdi3.2504","article-title":"Activated phosphoinositide 3-kinase delta syndrome: pathogenesis, clinical manifestations, and treatment.","volume":"2","author":"Zhu","year":"2024","journal-title":"Pediatr Discov."},{"key":"B8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1186\/s12887-025-06286-0","article-title":"A rare case report of activated PI3K delta syndrome (APDS): diagnostic pitfalls.","volume":"25","author":"Ahmad Shawaludin","year":"2025","journal-title":"BMC Pediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e90448","DOI":"10.7759\/cureus.90448","article-title":"Activated PI3 kinase delta syndrome: molecular pathogenesis and emerging therapeutics.","volume":"17","author":"Alraqibah","year":"2025","journal-title":"Cureus."},{"key":"B10","doi-asserted-by":"publisher","first-page":"114499","DOI":"10.1016\/j.jpeds.2025.114499","article-title":"Overlapping clinical phenotypes in patients with primary ciliary dyskinesia or activated phosphoinositide 3-kinase delta syndrome.","volume":"280","author":"Shapiro","year":"2025","journal-title":"J Pediatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccm.2021.11.008","article-title":"Diagnosis of primary ciliary dyskinesia.","volume":"43","author":"Goutaki","year":"2022","journal-title":"Clin Chest Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.medcli.2023.06.006","article-title":"Cystic fibrosis: epidemiology, clinical manifestations, diagnosis and treatment. Fibrosis qu\u00edstica: epidemiolog\u00eda, cl\u00ednica, diagn\u00f3stico y tratamiento.","volume":"161","author":"Diab C\u00e1ceres","year":"2023","journal-title":"Med Clin (Barc)."},{"key":"B13","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/cells13110974","article-title":"Primary ciliary dyskinesia: a clinical review.","volume":"13","author":"Despotes","year":"2024","journal-title":"Cells."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/jcp.23046","article-title":"The phosphoinositide 3\u2019-kinase p110\u03b4 modulates contractile protein production and IL-6 release in human airway smooth muscle.","volume":"227","author":"Ge","year":"2012","journal-title":"J Cell Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1124\/jpet.110.173583","article-title":"Phosphatidylinositol 3-kinase isoform-specific effects in airway mesenchymal cell function.","volume":"337","author":"Moir","year":"2011","journal-title":"J Pharmacol Exp Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2214\/AJR.06.0965","article-title":"High-resolution CT of patients with primary ciliary dyskinesia.","volume":"188","author":"Kennedy","year":"2007","journal-title":"AJR Am J Roentgenol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood.2019002072","article-title":"Increased activation of PI3 kinase-\u03b4 predisposes to B-cell lymphoma.","volume":"135","author":"Durandy","year":"2020","journal-title":"Blood."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e20250174","DOI":"10.70962\/jhi.20250174","article-title":"Lymphoproliferation in inborn errors of immunity: from challenging diagnosis to histologic revision.","volume":"2","author":"Moratti","year":"2026","journal-title":"J Hum Immun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1583405","DOI":"10.3389\/fimmu.2025.1583405","article-title":"EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase \u03b4 syndrome type 1 (APDS1): a case report and literature review.","volume":"16","author":"Xiang","year":"2025","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3389\/fimmu.2017.02005","article-title":"Epstein-barr virus susceptibility in activated PI3K\u03b4 syndrome (APDS) immunodeficiency.","volume":"8","author":"Carpier","year":"2018","journal-title":"Front Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"210.e","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study.","volume":"138","author":"Elkaim","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/MPH.0000000000001487","article-title":"A rare case of activated phosphoinositide 3-kinase delta syndrome (APDS) presenting with hemophagocytosis complicated with Hodgkin lymphoma.","volume":"42","author":"Cansever","year":"2020","journal-title":"J Pediatr Hematol Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"108543","DOI":"10.1016\/j.clim.2020.108543","article-title":"Paediatric MAS\/HLH caused by a novel monoallelic activating mutation in p110\u03b4.","volume":"219","author":"Lougaris","year":"2020","journal-title":"Clin Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"IJH25","DOI":"10.2217\/ijh-2020-0002","article-title":"Infectious mononucleosis mimicking Epstein-Barr virus positive diffuse large B-cell lymphoma not otherwise specified.","volume":"9","author":"Kanderi","year":"2020","journal-title":"Int J Hematol Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/his.14652","article-title":"Epstein-Barr virus infection patterns in nodular lymphocyte-predominant Hodgkin lymphoma.","volume":"80","author":"Gerhard-Hartmann","year":"2022","journal-title":"Histopathology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1097\/PAS.0000000000000266","article-title":"Variable expression of B-cell transcription factors in reactive immunoblastic proliferations: a potential mimic of classical Hodgkin lymphoma.","volume":"38","author":"Treetipsatit","year":"2014","journal-title":"Am J Surg Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/ajcp\/aqab113","article-title":"Geographic variability of nodular lymphocyte-predominant Hodgkin lymphoma.","volume":"157","author":"Xia","year":"2022","journal-title":"Am J Clin Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/modpathol.2012.70","article-title":"Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features.","volume":"25","author":"Louissaint","year":"2012","journal-title":"Mod Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clim.2016.07.017","article-title":"Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase \u03b4 syndrome.","volume":"171","author":"Rae","year":"2016","journal-title":"Clin Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/pai.12585","article-title":"Activated PI3K\u03b4 syndrome type 2: two patients, a novel mutation, and review of the literature.","volume":"27","author":"Olbrich","year":"2016","journal-title":"Pediatr Allergy Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","article-title":"Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase \u03b4 syndrome: the European Society for immunodeficiencies-activated phosphoinositide 3-kinase \u03b4 syndrome registry.","volume":"9","author":"Maccari","year":"2018","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"605.e","DOI":"10.1016\/j.jaci.2017.11.042","article-title":"Mutations in PI3K110\u03b4 cause impaired natural killer cell function partially rescued by rapamycin treatment.","volume":"142","author":"Ruiz-Garc\u00eda","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B33","volume-title":"Leniolisib for Treating Activated Phosphoinositide 3-Kinase Delta Syndrome in People 12 Years and Over.","year":"2025"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \u201cactivated PI3K\u03b4 syndrome\u201d-targeted therapy with the PI3K\u03b4 inhibitor leniolisib.","volume":"130","author":"Rao","year":"2017","journal-title":"Blood."},{"key":"B35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s10875-024-01835-1","article-title":"Report of the Italian cohort with activated phosphoinositide 3-kinase \u03b4 syndrome in the target therapy era.","volume":"45","author":"Barzaghi","year":"2024","journal-title":"J Clin Immunol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1807946\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:51:19Z","timestamp":1775836279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1807946\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":35,"alternative-id":["10.3389\/fmed.2026.1807946"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1807946","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1807946"}}